WELLlife COVID-19/Influenza A&B Home Test on Sale for Amazon Prime Day

October 03, 2024 11:00 PM AEST | By Cision

WELLlife COVID-19/Influenza A&B Home Test on Sale for Amazon Prime Day — Image source: Kalkine Media

Recent News

AMD stock: Upcoming AI event ‘could be catch-up catalyst’, says BofA

PNC 2023 Corporate Responsibility Report: Building Connections With Pe...

HK Acquisition Corporation Announces EGM to Approve De-SPAC Transactio...

Eight Strategies to Become a Better Water Steward

Standfirst: Welllife, a Flu home test in addition to COVID-19

BOLINGBROOK, Ill., Oct. 3, 2024 /PRNewswire/ -- WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing this flu season. The WELLlife COVID-19/Influenza A&B Home Test will be on sale for $22.98/box during the Amazon Prime Day event, from Oct. 8 to Oct. 9.

The WELLlife home test offers a fast, reliable way to detect Flu A/Flu B as well as COVID-19—three common respiratory illnesses with overlapping symptoms but requiring different treatments. Authorized by the United States Food and Drug Administration (FDA) under Emergency Use Authorization (EUA), the WELLlife Home Test is available without a prescription both online and in stores.

Clearer answers for informed decisions
Previously, testing for Flu could only be conducted by healthcare professionals in clinical settings. During peak seasons, long waits at the doctor's office can lead to delays in diagnosis and treatment.

WELLlife closes this gap by offering the FDA-Emergency Use Authorized, at-home test that can detect both Flu strains (A and B) alongside SARS-CoV-2. If you're experiencing cold-like symptoms, our test can help identify it's a Flu or COVID. This at-home option provides fast results and eliminates the need to visit healthcare facilities, reducing the risk of spreading virus in public spaces and helping to start treatment sooner.

A trusted choice for dependable results
With a single nasal swab, the WELLlife home test provides accurate results in just 10 minutes. It offers industry-leading accuracy, which was clinically proven to exceed FDA's criteria.

Easy testing at home
Avoid the stress of scheduling doctor's appointments or visiting the clinic. The WELLlife home test is easy to use for nearly everyone, including the elderly and parents with young children. With clear, simple instructions and non-intrusive procedures, the test can be easily conducted at home.

Backed by quality
With over 30 years of experience in the development and manufacturing of medical diagnostic products, WELLlife applies rigorous quality standards across its entire supply chain, which ensures consistent quality and supply reliability, even during periods of high demand.

Availability
The WELLlife COVID-19/Influenza A&B Home Test is available in multiple pack size options on Amazon.com and welllifebio.com, tailored for your needs.

About WELLlife
WELLlife is a leading brand of rapid testing products from Wondfo USA CO., Ltd. We're all about making health tests easy, fast, and hassle-free with our user-friendly test kits, putting reliable testing right at your fingertips. Backed by over 30 years of medical diagnostics expertise, a solid quality management system, and innovative R&D, WELLlife offers ease-to-use testing solutions you can count on. Welllife, A Flu test and more!

Media contact
Cecilia Qian
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.